H-CYTE, INC. (MDVX) [Rocket]

Overview

H-CYTE, INC. (MDVX)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/03/2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
07/11/2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ...
05/15/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/18/2023	8-K	Quarterly results
04/03/2023	NT 10-K	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/02/2023	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
02/10/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	1.6	2.2	8.3	7.9	0.4	14.9	5.6	0.0
Revenue growth	-25.1%	-74.2%	5.9%	1894.0%	-97.3%	166.8%
Cost of goods sold	0.7	0.8	2.1	2.4	-0.2	0.0	0.0	0.0
Gross profit	0.9	1.4	6.3	5.5	0.6	14.9	5.6	0.0
Gross margin	56.3%	64.3%	75.4%	70.0%	141.2%	100.0%	100.0%
Sales and marketing			4.9	1.9	0.9	0.4	0.1
Research and development	0.0	1.2	0.1		0.5	1.1	0.9	1.0
General and administrative	4.9	7.3	15.5	7.1	4.7	4.9	4.6	1.9
EBITA	-5.2	-7.1	-15.0	-3.6	-6.1	-4.6	-5.1	-2.9
EBITA margin	-322.2%	-329.8%	-180.3%	-45.5%	-1533.1%	-31.1%	-91.5%
Amortization of intangibles						0.2	0.4
EBIT	-5.2	-7.1	-15.0	-3.6	-6.1	-4.8	-5.5	-2.9
EBIT margin	-322.2%	-329.8%	-180.3%	-45.5%	-1533.1%	-32.3%	-99.2%
Pre-tax income	-4.8	-6.5	-29.8	-4.4	-6.5	-13.3	-5.6	-2.9
Income taxes	0.0	0.0	0.0	0.0	0.0	2.9	0.9	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%				0.0%
Earnings from continuing ops	-4.8	-6.8	-33.2	-4.4	-6.5	-13.3	-5.6	-2.9
Earnings from discontinued ops						-2.9
Net income	-4.8	-6.8	-33.2	-4.4	-6.5	-16.2	-6.5	-2.9
Net margin	-297.8%	-315.3%	-397.7%	-55.7%	-1633.2%	-108.9%	-116.8%

Diluted EPS	($0.03)	($0.06)	($0.34)	($0.13)	($0.34)	($1.00)	($0.51)	($0.37)
Shares outstanding (diluted)	145.7	111.5	96.4	33.7	19.1	13.3	10.9	7.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.